BackTable Vascular & Interventional

Ep. 188 Deep Dive on Anticoagulation Regimens for Venous Interventions with Dr. Fred Bertino


Listen Later

Dr. Fred Bertino educates us on anticoagulation regimens for patients after deep venous interventions.


---


CHECK OUT OUR SPONSOR


RADPAD® Radiation Protection

https://www.radpad.com/


---


EARN CME


Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs: https://earnc.me/NwME1W


---


SHOW NOTES


In this episode, pediatric interventional radiologist Dr. Fred Bertino joins our host Dr. Chris Beck to discuss new data on anticoagulation regimes before, during, and after venous stenting and/or mechanical thrombectomy.


Dr. Bertino starts by reviewing the difference between the compositions of arterial versus venous clots. Arterial clots are formed as a response to endothelial injury and exposure of von Willebrand factor, so these clots are usually platelet-rich. On the other hand, venous clots are formed due to stasis, and these are usually platelet-poor. Therefore, antiplatelet therapy may not be ideal for venous clots. However, Dr. Bertino notes that stent placement can cause endothelial injury at the apposition points of the stent, so the treatment algorithm can become more complex in these cases.


The doctors note that there are non-thrombotic diseases that require venous stenting, such as May Thurner syndrome. Dr. Bertino says that addressing this early in the pediatric population can be a safe way to prevent future DVT, as long as children are monitored carefully.


Next, Dr. Bertino walks us through his preferred anticoagulation routine for stent placement. Four hours before the procedure, he starts with a dose of Factor Xa inhibitor (apixaban or rivaroxaban) to prevent in-stent thrombosis. The patient is maintained on heparin during the procedure. After the procedure, anticoagulation varies depending on whether a stent was placed, or solely mechanical thrombectomy was performed.


Finally, the doctors discuss preferred anticoagulation for special scenarios such as covered stents (which can be more thrombophilic) and patients with malignancies. Dr. Bertino encourages IRs to reach out to their hematology colleagues to stay updated on anticoagulation research, as well as physical and occupational therapists to help patients form long-term DVT prevention plans.


---


RESOURCES


Find this episode on backtable.com to see the full library of resources mentioned by Dr. Fred Bertino.

...more
View all episodesView all episodes
Download on the App Store

BackTable Vascular & InterventionalBy BackTable

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

133 ratings


More shows like BackTable Vascular & Interventional

View all
Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

32,141 Listeners

Behind The Knife: The Surgery Podcast by Behind The Knife: The Surgery Podcast

Behind The Knife: The Surgery Podcast

1,303 Listeners

Pivot by New York Magazine

Pivot

9,110 Listeners

How I Built This with Guy Raz by Guy Raz | Wondery

How I Built This with Guy Raz

30,252 Listeners

White Coat Investor Podcast by Dr. Jim Dahle of the White Coat Investor

White Coat Investor Podcast

2,426 Listeners

The Daily by The New York Times

The Daily

111,276 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,545 Listeners

The Daily Show: Ears Edition by iHeartPodcasts and Paramount Podcasts

The Daily Show: Ears Edition

14,192 Listeners

Money Meets Medicine by Doctor Podcast Network, Jimmy Turner MD

Money Meets Medicine

218 Listeners

The Passive Income MD Podcast by Peter Kim, MD

The Passive Income MD Podcast

279 Listeners

The Kinked Wire by Society of Interventional Radiology

The Kinked Wire

6 Listeners

The Prof G Pod with Scott Galloway by Vox Media Podcast Network

The Prof G Pod with Scott Galloway

5,285 Listeners

BackTable MSK by BackTable

BackTable MSK

2 Listeners

Prof G Markets by Vox Media Podcast Network

Prof G Markets

1,024 Listeners

BackTable Tumor Board by BackTable Inc.

BackTable Tumor Board

0 Listeners